QA: Cornerstone Therapeutics INC in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001145404_2013_Cornerstone_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001145404, Cornerstone Therapeutics INC

  xvar xval
0 AssetsCurrent 102,566,000
1 IntangibleAssetsNetIncludingGoodwill 265,467,000
2 PropertyPlantAndEquipmentNet 1,310,000
3 remainder_Assets 32,000
4 LiabilitiesCurrent 66,825,000
5 LiabilitiesNoncurrent 94,332,000
6 remainder_Liabilities 42,045,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 46,404,000
9 ResearchAndDevelopmentExpense 4,273,000
10 remainder_Expenses 73,500,000
11 remainder_Revenues 116,084,000
12 remainder_NetIncome -3,795,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 369,375,000
1 Liabilities 203,202,000
2 Expenses 124,177,000
3 Revenues 116,084,000
4 StockholdersEquity 166,173,000
5 NetIncome -11,888,000
6 ComprehensiveNetIncome -11,888,000
7 BaseVar 408,316,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.22
9 EconomicCapitalRatio 2.48

Edgar->Model Mapping

Feature Distribution

Change over Time